This proposal seeks training for the P.I. in the molecular biology of skin development. The project will take place in the laboratory of Dr. Merton Bernfield at the facilities of the Harvard Medical School and Children's Hospital. The laboratory is an outstanding intellectual environment consisting of 5 Ph.D. and 3 M.D. post-doctorals. A major interest of this laboratory is the cell surface molecule syndecan. Syndecan is a prototype cell surface proteoglycan that binds extracellular matrix and growth factors, molecules that promote differentiation. Mammary epithelial cells made syndecan-deficient change cell morphology, decrease expression of cell adhesion molecules, and have disorganized F-actin. Syndecan is also expressed in a strictly defined pattern at epithelial-mesenchymal junctions during morphogenesis, is highly conserved between species, and exists in tissue type-specific polymorphic forms. Thus, syndecan may play an important role in tissue interaction during development. This proposal is designed to investigate the functions of syndecan in order to further understand epithelial-mesenchymal interactions in development. To accomplish this a structure/function analysis is presented of syndecan. This approach will define selected functions of syndecan by mapping function to specific structural domains. Specifically, this proposal seeks to: (i) Identify and characterize syndecan expression in selected cell types that lack expression of syndecan at the cell surface. (ii) Transfect syndecan and mutant constructs into those cells identified as originally lacking surface expression such that they will now express syndecan or its mutant construct. (iii) Analyze functional response in terms of cell morphology, matrix adhesion, cell-cell adhesion, cell motility, and bFGF binding and activity in appropriate transfectants, thus identifying structure- function relationships. Completion of these studies will provide the P.I. with investigative skills in molecular and developmental biology. This training will permit the P.I. to continue his career as an independent investigator working on problems relevant to growth and development of the skin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AR001874-02
Application #
3079348
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1992-02-04
Project End
1997-01-31
Budget Start
1993-02-01
Budget End
1994-01-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Suppiah, Ravi; Flossman, Oliver; Mukhtyar, Chetan et al. (2011) Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index. Ann Rheum Dis 70:80-5
Silva, Francisco; Seo, Philip; Schroeder, Darrell R et al. (2011) Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort. Arthritis Rheum 63:2495-503
Suppiah, Ravi; Judge, Andrew; Batra, Rajbir et al. (2011) A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken) 63:588-96
Herlyn, Karen; Hellmich, Bernhard; Seo, Philip et al. (2010) Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res (Hoboken) 62:1639-45
Gallo, R; Kim, C; Kokenyesi, R et al. (1996) Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J Invest Dermatol 107:676-83
Kim, C W; Goldberger, O A; Gallo, R L et al. (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 5:797-805
Gallo, R L; Ono, M; Povsic, T et al. (1994) Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci U S A 91:11035-9
Bernfield, M; Hinkes, M T; Gallo, R L (1993) Developmental expression of the syndecans: possible function and regulation. Dev Suppl :205-12
Bernfield, M; Kokenyesi, R; Kato, M et al. (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365-93